Clinical Trials Browser

Terminated × Lymphoma × blinatumomab × Clear all

NCT02811679 2025-05-23

A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma

Phase 2 Terminated

13 enrolled 12 charts

Lymphoma, Lymphoma, Non-Hodgkin